Nobel Laureate Thomas Südhof and bit.bio CEO Mark Kotter to Lead Fireside Chat on Programming Human Cells at SynBioBeta

CAMBRIDGE, England--(BUSINESS WIRE)-- #Genomics--bit.bio, the company coding human cells for novel cures, and a pioneer in the field of synthetic biology, today announces it will participate in an engaging fireside chat at SynBioBeta 2024 featuring Nobel Laureate Thomas Südhof and bit.bio founder Mark Kotter. Dr. Südhof, a world-renowned molecular and cellular neuroscientist and professor at Stanford University, will be joined by Dr. Kotter, a stem cell biologist, neurosurgeon at the University of Cambridg